Marien Hospital

Düsseldorf 40479

0 studies enrolling now · 4 studies all time

What they study most

Anemia, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes

Studies at this site

• Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes — Completed
• An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML) — Completed
• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes — Completed
• A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q — Completed